Pharma Jonpi . / 1.1 / .
10 septiembre 2021
Lurbinectedin Does Not Improve Overall SCLC Survival; Some Positive Action With Doxorubicin After Chemotherapy . Post by International Association for the Study of Lung Cancer .
Entrada más reciente
Entrada antigua
Inicio